TRANSPHARMAC LIMITED
Significant control: Nigel William Mccracken (25–50%), Michelle Denise Mccracken (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Transpharmac Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Transpharmac Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
TRANSPHARMAC LIMITED is an active private limited company (company number SC729695) incorporated on 14 April 2022, registered in Edinburgh. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 April 2026, showing net assets of −£7,070, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 1132% on the prior period (£685).
By net assets it sits in the bottom quarter of 62 comparable companies in Edinburgh (median £4,168, upper quartile £51k).
Ownership and control
- Dr Nigel William Mccracken
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mrs Michelle Denise Mccracken
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 14 April 20224 yrs ago
- Next accounts due
- 30 January 2028in 462 days
- Confirmation statement due
- 28 April 2027in 185 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2026 | −£7,070 | — | — | £18k | — | — | 0 |
| 30 April 2025 | £685 | — | — | £18k | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £-7,070 at 30 April 2026
- Net assets down 25% or more on the prior period-1132.1% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.56
- Incorporated two to five years agoIncorporated 14 April 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 462 days
- Confirmation statement duein 185 days
- Accounts period endNet liabilities £7,070 · micro accounts
- Accounts period endNet assets £685 · micro accounts
- Incorporated
Similar companies in Edinburgh
- BIOMARA LIMITEDEdinburgh · inc. Mar 2022
- ROSTRA THERAPEUTICS LTDEdinburgh · inc. Feb 2022
- MMWR LTDEdinburgh · inc. Jun 2022
- BRAIN HEALTH SCOTLAND LIFE SCIENCES LTDEdinburgh · inc. Jun 2022
- C-SOURCE RENEWABLES LIMITEDEdinburgh · inc. Jul 2022
- CODY GENETICS LIMITEDEdinburgh · inc. Aug 2022
All companies incorporated on 14 April 2022 · in Apr 2022.
Reminders for TRANSPHARMAC LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.